0001415889-24-021869.txt : 20240821 0001415889-24-021869.hdr.sgml : 20240821 20240821183807 ACCESSION NUMBER: 0001415889-24-021869 CONFORMED SUBMISSION TYPE: 4 PUBLIC DOCUMENT COUNT: 1 CONFORMED PERIOD OF REPORT: 20240819 FILED AS OF DATE: 20240821 DATE AS OF CHANGE: 20240821 REPORTING-OWNER: OWNER DATA: COMPANY CONFORMED NAME: Hannah Brendan CENTRAL INDEX KEY: 0001929422 ORGANIZATION NAME: FILING VALUES: FORM TYPE: 4 SEC ACT: 1934 Act SEC FILE NUMBER: 001-38890 FILM NUMBER: 241229707 MAIL ADDRESS: STREET 1: 269 EAST GRAND AVE CITY: SOUTH SAN FRANCISCO STATE: CA ZIP: 94080 ISSUER: COMPANY DATA: COMPANY CONFORMED NAME: Quince Therapeutics, Inc. CENTRAL INDEX KEY: 0001662774 STANDARD INDUSTRIAL CLASSIFICATION: BIOLOGICAL PRODUCTS (NO DIAGNOSTIC SUBSTANCES) [2836] ORGANIZATION NAME: 03 Life Sciences IRS NUMBER: 901024039 STATE OF INCORPORATION: CA FISCAL YEAR END: 1231 BUSINESS ADDRESS: STREET 1: 611 GATEWAY BLVD., SUITE 273 CITY: SOUTH SAN FRANCISCO STATE: CA ZIP: 94080 BUSINESS PHONE: 415-910-5717 MAIL ADDRESS: STREET 1: 611 GATEWAY BLVD., SUITE 273 CITY: SOUTH SAN FRANCISCO STATE: CA ZIP: 94080 FORMER COMPANY: FORMER CONFORMED NAME: Cortexyme, Inc. DATE OF NAME CHANGE: 20160104 4 1 form4-08212024_100803.xml X0508 4 2024-08-19 0001662774 Quince Therapeutics, Inc. QNCX 0001929422 Hannah Brendan C/O QUINCE THERAPEUTICS, INC. 611 GATEWAY BLVD, SUITE 273 SOUTH SAN FRANCISCO CA 94080 false true false false CHIEF BUSINESS OFFICER AND COO 0 Common Stock 2024-08-19 4 P 0 2155 0.58 A 259771 D Common Stock 2024-08-20 4 P 0 2500 0.61 A 262271 D Common Stock 2024-08-20 4 P 0 3424 0.60 A 265695 D Common Stock 2024-08-21 4 P 0 2280 0.61 A 267975 D Common Stock 2024-08-21 4 P 0 5000 0.62 A 272975 D Common Stock 2024-08-21 4 P 0 23565 0.63 A 296540 D /s/ Brendan Hannah 2024-08-21